The AlphaGenome Atlas, as described by DeepMind, represents a significant scaling of AI's role in genomics, shifting from targeted analysis to a precomputed, all-encompassing reference. The key question is whether this 'atlas' will function as a useful guide or an overwhelming, potentially misleading catalog. In our view, the success of such a tool hinges less on its computational prowess and more on how well it integrates with, and is validated by, traditional wet-lab biology.
The risk is that the scientific community may treat these AI scores as de facto answers, potentially obscuring the nuanced, context-dependent nature of gene regulation that algorithms still struggle to capture.